Entourage Health Corp.

ENTG

CA2938611001

Pharmaceuticals

Delayed Toronto S.E. Other stock markets 20:15:41 16/07/2024 BST			5-day change	1st Jan Change
0.01 ^CAD	-33.33%		0.00%	-33.33%

06-12	Transcript : Entourage Health Corp. - Shareholder/Analyst Call
05-28	Transcript : Entourage Health Corp., Q1 2024 Earnings Call, May 28, 2024

WeedMD Inc. Appoints Kevin McGovern to Its Board of Directors

January 15, 2018 at 11:30 am

WeedMD Inc. announced the appointment of Kevin McGovern as a board director. Kevin McGovern is the Chairman of McGovern Capital.

Latest news about Entourage Health Corp.

Transcript : Entourage Health Corp. - Shareholder/Analyst Call	06-12
Transcript : Entourage Health Corp., Q1 2024 Earnings Call, May 28, 2024	05-28
Entourage Health Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-28	CI
Entourage Health Introduces New Product Launches and Expands Market Reach of Leading Brand Dime Bag	05-08	CI
Entourage Health Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	04-30	CI
Entourage Health Corp. Announces Resignation of Lu Cacioppo from its Board of Directors	01-31	CI
Entourage Health Provides Corporate Update	12-05	MT
Entourage Health Corp. Announces Vincent Doré, Entourage's Chief Legal Officer and Corporate Secretary, Will Step Down, Effective December 18, 2023	12-05	CI
Transcript : Entourage Health Corp., Q3 2023 Earnings Call, Nov 28, 2023	11-28
Entourage Health Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-26	CI
Entourage Health Signs Amended Supply Agreement With HEXO	15/09/23	MT
Entourage Health Brief: Announcing Amendment to Key Supply Agreement	15/09/23	MT
Entourage Health Announces Amendment to Key Supply Agreement	15/09/23	CI
Entourage Health Posts Q2 Results; Shares Up	30/08/23	MT
Transcript : Entourage Health Corp., Q2 2023 Earnings Call, Aug 30, 2023	30/08/23
Entourage Health Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28/08/23	CI
Entourage Health Announces New Product Offerings	24/08/23	MT
Entourage Health Corp. Launches Dime Bag Branded Pre-Rolls and Introduces Syndicate: A Collective of Craft Cannabis	24/08/23	CI
Entourage Health Announces International Sale of Bulk Cannabis to Australia	04/07/23	MT
Entourage Health Corp. Announces International Sale of Bulk Cannabis to Australia	04/07/23	CI
An unknown buyer acquired Strathroy facility of Entourage Health Corp.	19/06/23	CI
Entourage Health Restructures Senior Secured Debt	19/06/23	MT
Entourage Health Corp. Announces Restructuring of Senior Secured Debt	19/06/23	CI
Transcript : Entourage Health Corp. - Shareholder/Analyst Call	14/06/23
Transcript : Entourage Health Corp., Q1 2023 Earnings Call, May 30, 2023	30/05/23

Entourage Health Corp. is a Canada-based license holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 26,000 square feet indoor facility in Aylmer, Ontario (the Aylmer Facility), specializing in product development and fulfillment for both adult-use and medical cannabis. The Company is focused on building a portfolio of brands in the Canadian market, including its brand Color Cannabis, mainstream brand Saturday Cannabis, medical cannabis product brand Starseed Medicinal and its craft cannabis brand Syndicate Cannabis. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including oils, capsules, soft chews, topicals, beverages and vapes, for sale in both the medical and adult-use markets across Canada. Its elite adult-use product portfolio includes Color Cannabis, Saturday Cannabis and now Dime Bag and Syndicate, sold across eight provincial distribution agencies.

Sector

Pharmaceuticals

Calendar

27/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company